We’re delighted to announce a new round of funding and
the addition of two members to our executive board.
Since launching commercially in 2021, we’ve had the privilege to evaluate and treat over 150K people with hearing loss using our all-in-one hearing assessment platform — granting us one of the largest digital databases of ear and hearing health records globally.
While we’re very pleased with the impact we’ve made in only 12 short months, nearly 20% of the global population is still living with hearing loss — and that number is projected to rise. That’s why we’re dedicated to accelerating our growth across the UK, Europe, and US.
$8m in new funding — financed by healthcare entrepreneurs Maurice Ferre and Arjun Desai, joined by a global consortium of investors — is helping us bring our ambition to life.
"We are incredibly humbled to be supported by such an experienced and distinguished group of investors. This funding will fuel our growth and gives Tympa the opportunity to revolutionise an important area of unmet need in the healthcare sector."
Dr. Krishan Ramdoo, CEO & Founder of TympaHealth
Additionally, we’ve appointed two new members to our executive board: Arjun Desai and Karin Ajmani. Desai has scaled several medical and healthcare technology companies, including leading global teams at Johnson and Johnson Innovation and Insightec. Ajmani holds board positions at multiple digital health companies — most recently serving as President and Chief of Strategic Development at Progyny.
"More and more research shows the significant correlation between hearing loss and patient falls, social isolation and dementia…It is cost-effective solutions like Tympa, which focus on preventative care, that are high on the agenda at the payor/provider level. I am thrilled to be joining the board at TympaHealth."
Karin Ajmani, investor
The advances made possible by our recent funding, alongside the expertise and commitment of our new board members, position us to continue expanding the democratisation of ear and hearing care.
TympaHealth_PressRelease_021722_UK
Press Release
